Dharmacon, Akceli Sign Research Agreement to Combine Technologies

Nov 03, 2003

NEW YORK, Nov. 3 (GenomeWeb News) - Dharmacon has signed on to a research collaboration with Akceli, of Cambridge, Mass. to study ways to combine Dharmacon's short interfering RNA with Akceli's reverse-transfection technology, the companies said today.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Standards Needed

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

Faster Profiles

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

Conflict Search

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

This Week in Science

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.

Main menu